Purchases and Sales Made in Q1 2025 in Theravance Biopharma, Inc. (TBPH)
This table provides information about the institutional ownership of Theravance Biopharma, Inc. (TBPH) during Q1 2025. The information is specifically focused on institutions that hold shares of Theravance Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-37.9K- 91.92% |
$320K - $397K
|
3.33K
$37.7K
|
|
|
May 13, 2025
Q1 2025
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-40.6K- 10.4% |
$342K - $425K
|
349K
$3.95M
|
|
|
May 15, 2025
Q1 2025
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-51.2K- 77.43% |
$432K - $536K
|
14.9K
$169K
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-62.8K- 28.58% |
$530K - $657K
|
157K
$1.77M
|
|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-156K- 12.74% |
$1.31M - $1.63M
|
1.07M
$12.1M
|
|
|
May 15, 2025
Q1 2025
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-277K- 63.1% |
$2.34M - $2.9M
|
162K
$1.83M
|